TrivarX Limited (MDBIF)
OTCMKTS · Delayed Price · Currency is USD
0.0025
-0.0132 (-84.08%)
At close: Jan 6, 2026
TrivarX Market Cap
TrivarX has a market cap or net worth of $25.37 million as of February 12, 2026. Its market cap has increased by 388.81% in one year.
Market Cap
25.37M
Enterprise Value
24.60M
Revenue
675.98K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 5.91M to 25.37M, an increase of 329.46%. That is a compound annual growth rate of 6.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 25.46M | 74.11% |
| Dec 31, 2025 | 14.62M | 216.31% |
| Dec 30, 2024 | 4.62M | -33.14% |
| Dec 29, 2023 | 6.91M | 54.30% |
| Dec 28, 2022 | 4.48M | -45.54% |
| Dec 30, 2021 | 8.23M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revium Rx. | 91.09M |
| Vaso Corporation | 31.06M |
| Veri Medtech Holdings | 20.00M |
| DATATRAK International | 15.22M |
| Pharma-Bio Serv | 13.59M |
| CareView Communications | 13.51M |
| BioRegenx | 13.47M |
| Welsis | 12.66M |